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Abstract 
DNA methylation is among the most studied epigenetic marks, with essential influence 
on biological growths, disease developments and potential public health benefits. Modified from 
the well-established measuring method bisulfite sequencing (BS-seq), single-cell bisulfite 
sequencing (scBS-seq) emerged recently to identify DNA methylation status within a single cell 
to profile and study heterogeneities better. With the unique features of the single-cell DNA 
methylation data, there is in need of developing a new method to assign the methylation status 
for each CpG site more accurately and precisely to represent the underlying truth. In this study, 
we propose a method using Bayes rule and compare its performance with a simple one-third rule 
method. A simulation study with various settings is conducted to compare the accuracy, 
precision and bias. The Bayes’ method shows an improvement in dimensions of accuracy and 
bias.  
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1.0 INTRODUCTION 
DNA methylation is a biochemical process where a methyl group (CH3) is added to the 
cytosine or adenine. In mammalian cells, the change happens almost exclusively on the 5 
position of cytosine (C) when it is followed by guanine (G), called CpG site. This modification 
of DNA has been found to play important roles in genomic imprinting, genome stability and 
regulation of gene expression without altering the DNA sequence itself. Dysregulation of DNA 
methylation has been found to be related to many different diseases, particularly in cancer with 
overall genomic demethylation and gene specific hypermethylation (Bird, 2002; Kriaucionis & 
Heintz, 2009; Meissner et al., 2008; Seisenberger et al., 2012; Szulwach et al., 2011; 
Teschendorff et al., 2010). DNA methylation was the first discovered and remains one of the 
most studied and best understood epigenetic marks. A recent extensive expansion of our 
knowledge on epigenetic changes has revealed that the impact of genetic features on the 
biological phenotype changes is not direct, but through epigenetic changes (Figure 1), which 
strongly suggests that disease development is better reflected by epigenetic than genetic features. 
Therefore, epigenetic marks such as DNA methylation can become more conclusive and 
predictive biomarkers for the detection and diagnosis of many diseases. 
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Figure 1 Epigenotype as the intermediate phenotype 
 
Detection technologies of DNA methylation have been shifted from mass spectrometry 
and array-based assays to sequencing based technologies. Treatment of DNA with sodium 
bisulfite causes the conversion of unmethylated cytosines to uracils while methylated cytosines 
remain protected from this conversion. The consequence of this process is that methylated and 
unmethylated CpG sites can be identified using next generation sequencing (NGS). Over the past 
decade, protocols for sodium bisulfite treatment of DNA coupled with NGS (BS-seq) have 
become the gold standard approach for assessment of genome-wide DNA methylation. This 
trend is partially due to high level of fidelity and reproducibility of BS-seq, with rates well above 
99% generally being achieved for conversion of unmethylated cytosine residues to uracil. Series 
of key findings and technological advances over the past years have led to our current ability for 
quantitative query of the methylation status across the whole genome. BS-seq has brought 
revolutionary basepair resolution to study genome wide DNA methylation. Whole genome 
bisulfite sequencing (WGBS) provides the first and still remains the only method to obtain 
accurate, quantitative estimates of the percent of cells in a population that are methylated at each 
of the millions of CpG sites across the entire genome. 
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DNA methylation is heterogeneous even among the same type of tissue within the same 
individuals. This heterogeneity of DNA methylation patterns may be partially responsible for the 
heterogeneity of the cell populations. The recently development of single cell Bisulfite 
sequencing (scBS-seq) technology has opened the door to study cell specific methylation 
patterns (Farlik et al., 2015; Smallwood et al., 2014). Each dataset generated by scBS-seq 
provides methylation information for a single cell. Although the short length of sequencing reads 
generated by scBS-seq is not a major concern, the low genomic coverage (~20% of CpGs) 
presents a major statistical challenge in characterizing cell specific information. Another 
challenge in the analysis of these types of data in diploid organisms such as human is the 
presence of allele specific methylation patterns. These challenges and others must be addressed 
to facilitate the identification of global and local methylation levels along with spatial 
methylation patterns within each cell.    
Unlike a regular bisulfite sequencing dataset composed of a mixed cell population which 
is epigenetically heterogeneous, a diploid single-cell dataset is expected to display methylation 
levels only of 0%, 50% or 100% at an individual CpG site. Some observed data in reality can 
deviate from these percentages caused by technical artifacts such as sequencing and mapping 
errors. When a CpG site is mapped with multiple reads, one simple way to call the CpG 
methylation status is using one-third rule, in which we set 1/3 and 2/3 as cutoffs and assign data 
not higher than 1/3 to 0%, not lower than 2/3 to 100%, and any level in between to 50%. In this 
thesis, we address this problem by proposing a statistical method based on Bayes’ rule to better 
identify the underlying methylation status for each of the millions of CpG sites. We will compare 
the performance of this method to the 1/3 rule using a simulation study and perform a real data 
analysis by applying this method. 
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2.0 METHODS 
2.1 BAYES’ RULE METHOD 
Single cell DNA methylation data only include methylation status at CpG sites that are 
covered by some sequence reads. Let 𝑛𝑛𝑠𝑠𝑠𝑠 and 𝑦𝑦𝑠𝑠𝑠𝑠 be the total number of reads and methylated 
reads in sample 𝑠𝑠  at CpG site 𝑖𝑖 , then if this CpG site is methylated 𝑛𝑛𝑠𝑠𝑠𝑠  = 𝑦𝑦𝑠𝑠𝑠𝑠  and if it is 
unmethylated 𝑦𝑦𝑠𝑠𝑠𝑠 = 0. For diploid organisms, methylation status could be different for each 
allele. Therefore, the methylation status in each of the CpG sites can only be 0%, 50%, or 100%. 
However, due to sequencing and mapping errors, and potential insufficient bisulfite conversion 
for one of both alleles, we frequently observe any methylated proportion of reads. One simple 
method is to separate these three statuses with so called one-third rule: 0 if  𝑦𝑦𝑠𝑠𝑠𝑠/𝑛𝑛𝑠𝑠𝑠𝑠 ≤ 1/3, ½ if 
1
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< 𝑦𝑦 𝑠𝑠𝑠𝑠/𝑛𝑛𝑠𝑠𝑠𝑠 < 2/3, and 1 if if 𝑦𝑦𝑠𝑠𝑠𝑠/𝑛𝑛𝑠𝑠𝑠𝑠 ≥ 2/3. Then we combine this methylation status to make 
a summary data.  
Another more rigorous way is to estimate the methylation status by incorporating more 
information. Let 𝑠𝑠𝑠𝑠𝑠𝑠 be the underlying methylation status for CpG site 𝑖𝑖 in sample 𝑠𝑠. Then as we 
discussed above, it can only be 0, ½ or 1.  Let 𝑝𝑝𝑠𝑠𝑠𝑠 be the true proportion of methylated reads by 
considering the error rates, in which 𝑝𝑝𝑠𝑠𝑠𝑠 ≤ 𝑝𝑝𝑎𝑎 if 𝑠𝑠𝑠𝑠𝑠𝑠 = 0, 𝑝𝑝𝑏𝑏 ≤ 𝑝𝑝𝑠𝑠𝑠𝑠 ≤ 𝑝𝑝𝑐𝑐 if 𝑠𝑠𝑠𝑠𝑠𝑠 = ½ and 𝑝𝑝𝑠𝑠𝑠𝑠 ≥ 𝑝𝑝𝑑𝑑 
if 𝑠𝑠𝑠𝑠𝑠𝑠 = 1.   
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Here 𝑦𝑦𝑠𝑠𝑠𝑠|𝑝𝑝𝑠𝑠𝑠𝑠~𝐵𝐵𝑖𝑖𝑛𝑛(𝑛𝑛𝑠𝑠𝑠𝑠 ,𝑝𝑝𝑠𝑠𝑠𝑠), and 𝑃𝑃(𝑝𝑝𝑠𝑠𝑠𝑠|𝑦𝑦𝑠𝑠𝑠𝑠 ,𝑛𝑛𝑠𝑠𝑠𝑠) = 𝑃𝑃(𝑦𝑦𝑠𝑠𝑠𝑠|𝑝𝑝𝑠𝑠𝑠𝑠,𝑛𝑛𝑠𝑠𝑠𝑠)𝑃𝑃(𝑝𝑝𝑠𝑠𝑠𝑠|𝑛𝑛𝑠𝑠𝑠𝑠)/𝑃𝑃(𝑦𝑦𝑠𝑠𝑠𝑠|𝑛𝑛𝑠𝑠𝑠𝑠) by 
following Bayes’ Rule.  Our goal is to impute the status of methylation level for CpG site 𝑖𝑖 given 
data (𝑦𝑦𝑠𝑠𝑠𝑠,𝑛𝑛𝑠𝑠𝑠𝑠).   
Our proposed method is based on restrictedly maximizing posterior likelihood function 
𝑃𝑃(𝑝𝑝𝑠𝑠𝑠𝑠|𝑦𝑦𝑠𝑠𝑠𝑠, 𝑛𝑛𝑠𝑠𝑠𝑠). I.e. we compare the restricted maximums of likelihood when 𝑝𝑝𝑠𝑠𝑠𝑠 ≤ 𝑝𝑝𝑎𝑎 , 𝑝𝑝𝑏𝑏 <
𝑝𝑝𝑠𝑠𝑠𝑠 < 𝑝𝑝𝑐𝑐 , and 𝑝𝑝𝑠𝑠𝑠𝑠 ≥ 𝑝𝑝𝑑𝑑  and based on where the maximum falls, we assign 𝑠𝑠𝑠𝑠𝑠𝑠 = 0, 𝑠𝑠𝑠𝑠𝑠𝑠 = 12 or 
𝑠𝑠𝑠𝑠𝑠𝑠 = 1  respectively. Since the error rates are expected to be low at around 10%, we can 
reasonably assume 𝑝𝑝𝑎𝑎 = 0.1,𝑝𝑝𝑏𝑏 = 0.4,𝑝𝑝𝑐𝑐 = 0.6 and 𝑝𝑝𝑑𝑑 = 0.9. 
      𝑃𝑃(𝑝𝑝𝑠𝑠𝑠𝑠|𝑦𝑦𝑠𝑠𝑠𝑠, 𝑛𝑛𝑠𝑠𝑠𝑠) = 𝑃𝑃�𝑦𝑦𝑠𝑠𝑠𝑠�𝑝𝑝𝑠𝑠𝑠𝑠,𝑛𝑛𝑠𝑠𝑠𝑠�𝑃𝑃�𝑝𝑝𝑠𝑠𝑠𝑠�𝑛𝑛𝑠𝑠𝑠𝑠�𝑃𝑃�𝑦𝑦𝑠𝑠𝑠𝑠�𝑛𝑛𝑠𝑠𝑠𝑠�  
                                               = �𝑛𝑛𝑠𝑠𝑠𝑠𝑦𝑦𝑠𝑠𝑠𝑠�𝑝𝑝𝑠𝑠𝑠𝑠𝑦𝑦𝑠𝑠𝑠𝑠(1−𝑝𝑝𝑠𝑠𝑠𝑠)𝑛𝑛𝑠𝑠𝑠𝑠−𝑦𝑦𝑠𝑠𝑠𝑠𝑃𝑃(𝑝𝑝𝑠𝑠𝑠𝑠)
𝑃𝑃�𝑦𝑦𝑠𝑠𝑠𝑠�𝑛𝑛𝑠𝑠𝑠𝑠�
.   
Since the distribution function 𝑃𝑃(𝑦𝑦𝑠𝑠𝑠𝑠|𝑛𝑛𝑠𝑠𝑠𝑠)  and binomial coefficient �𝑛𝑛𝑠𝑠𝑠𝑠𝑦𝑦𝑠𝑠𝑠𝑠�  remain the 
same, P(𝑝𝑝𝑠𝑠𝑠𝑠|𝑦𝑦𝑠𝑠𝑠𝑠 ,𝑛𝑛𝑠𝑠𝑠𝑠) ∝ 𝑝𝑝𝑠𝑠𝑠𝑠𝑦𝑦𝑠𝑠𝑠𝑠(1 − 𝑝𝑝𝑠𝑠𝑠𝑠)𝑛𝑛𝑠𝑠𝑠𝑠−𝑦𝑦𝑠𝑠𝑠𝑠𝑃𝑃(𝑝𝑝𝑠𝑠𝑠𝑠). Here we only need to maximize 𝑓𝑓(𝑝𝑝𝑠𝑠𝑠𝑠) =
𝑝𝑝𝑠𝑠𝑠𝑠
𝑦𝑦𝑠𝑠𝑠𝑠(1 − 𝑝𝑝𝑠𝑠𝑠𝑠)𝑛𝑛𝑠𝑠𝑠𝑠−𝑦𝑦𝑠𝑠𝑠𝑠𝑃𝑃(𝑝𝑝𝑠𝑠𝑠𝑠). However, we don’t know 𝑃𝑃(𝑝𝑝𝑠𝑠𝑠𝑠), which is the overall distribution 
of methylation status of all CpG sites. We propose first to use one-third rule and estimate 𝑃𝑃(𝑝𝑝𝑠𝑠𝑠𝑠) 
with this result, then use this estimated 𝑃𝑃�(𝑝𝑝𝑠𝑠𝑠𝑠) to maximize 𝑓𝑓(𝑝𝑝𝑠𝑠𝑠𝑠) under three restrictions.   
We denote the observed methylation level ?̂?𝑝𝑠𝑠𝑠𝑠 = 𝑦𝑦𝑠𝑠𝑠𝑠/𝑛𝑛𝑠𝑠𝑠𝑠 , and let 𝑃𝑃�(𝑠𝑠𝑠𝑠𝑠𝑠 = 0) = 𝜋𝜋�𝑠𝑠(0) , 
𝑃𝑃�(𝑠𝑠𝑠𝑠𝑠𝑠 = 1/2) = 𝜋𝜋�𝑠𝑠(1/2)  and 𝑃𝑃�(𝑠𝑠𝑠𝑠𝑠𝑠 = 1) = 𝜋𝜋�𝑠𝑠(1) . Since 𝑓𝑓(𝑝𝑝𝑠𝑠𝑠𝑠) = 𝑝𝑝𝑠𝑠𝑠𝑠𝑦𝑦𝑠𝑠𝑠𝑠(1 − 𝑝𝑝𝑠𝑠𝑠𝑠)𝑛𝑛𝑠𝑠𝑠𝑠−𝑦𝑦𝑠𝑠𝑠𝑠𝑃𝑃(𝑝𝑝𝑠𝑠𝑠𝑠)  is 
convex function on 𝑝𝑝𝑠𝑠𝑠𝑠, we can find in which restricted region the maximum of this likelihood 
function falls based on ?̂?𝑝𝑠𝑠𝑠𝑠 as follows: 
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(1) If ?̂?𝑝𝑠𝑠𝑠𝑠 ≤ 𝑝𝑝𝑎𝑎 , 𝑓𝑓(?̂?𝑝𝑠𝑠𝑠𝑠)  is the maximum for restricted region 𝑝𝑝𝑠𝑠𝑠𝑠 ≤ 𝑝𝑝𝑎𝑎 ; 𝑓𝑓(𝑝𝑝𝑏𝑏)  is the 
maximum for region 𝑝𝑝𝑏𝑏 < 𝑝𝑝𝑠𝑠𝑠𝑠 < 𝑝𝑝𝑐𝑐; 𝑓𝑓(𝑝𝑝𝑑𝑑) is the maximum for region 𝑝𝑝𝑠𝑠𝑠𝑠 ≥ 𝑝𝑝𝑑𝑑. We 
assign 𝑠𝑠𝑠𝑠𝑠𝑠 according to the region of 𝑝𝑝𝑠𝑠𝑠𝑠 which produced the maximized 𝑓𝑓(𝑝𝑝𝑠𝑠𝑠𝑠). 
(2) If 𝑝𝑝𝑏𝑏 ≤ ?̂?𝑝𝑠𝑠𝑠𝑠 ≤ 𝑝𝑝𝑐𝑐, 𝑓𝑓(𝑝𝑝𝑎𝑎) is the maximum for restricted region 𝑝𝑝𝑠𝑠𝑠𝑠 ≤ 𝑝𝑝𝑎𝑎; 𝑓𝑓(?̂?𝑝𝑠𝑠𝑠𝑠)is the 
maximum for region 𝑝𝑝𝑏𝑏 < 𝑝𝑝𝑠𝑠𝑠𝑠 < 𝑝𝑝𝑐𝑐; 𝑓𝑓(𝑝𝑝𝑑𝑑)is the maximum for region 𝑝𝑝𝑠𝑠𝑠𝑠 ≥ 𝑝𝑝𝑑𝑑. We 
assign 𝑠𝑠𝑠𝑠𝑠𝑠 according to the region of 𝑝𝑝𝑠𝑠𝑠𝑠 which produced the maximized 𝑓𝑓(𝑝𝑝𝑠𝑠𝑠𝑠). 
(3) If ?̂?𝑝𝑠𝑠𝑠𝑠 ≥ 𝑝𝑝𝑑𝑑 , 𝑓𝑓(𝑝𝑝𝑎𝑎)  is the maximum for restricted region 𝑝𝑝𝑠𝑠𝑠𝑠 ≤ 𝑝𝑝𝑎𝑎 ; 𝑓𝑓(𝑝𝑝𝑐𝑐) is the 
maximum for region 𝑝𝑝𝑏𝑏 < 𝑝𝑝𝑠𝑠𝑠𝑠 < 𝑝𝑝𝑐𝑐; 𝑓𝑓(?̂?𝑝𝑠𝑠𝑠𝑠)is the maximum for region 𝑝𝑝𝑠𝑠𝑠𝑠 ≥ 𝑝𝑝𝑑𝑑. We 
assign 𝑠𝑠𝑠𝑠𝑠𝑠 according to the region of 𝑝𝑝𝑠𝑠𝑠𝑠 which produced the maximized 𝑓𝑓(𝑝𝑝𝑠𝑠𝑠𝑠). 
(4) If 𝑝𝑝𝑎𝑎 < ?̂?𝑝𝑠𝑠𝑠𝑠 < 𝑝𝑝𝑏𝑏, 𝑓𝑓(𝑝𝑝𝑎𝑎) is the maximum for restricted region 𝑝𝑝𝑠𝑠𝑠𝑠 ≤ 𝑝𝑝𝑎𝑎; 𝑓𝑓(𝑝𝑝𝑏𝑏) is the 
maximum for region 𝑝𝑝𝑏𝑏 < 𝑝𝑝𝑠𝑠𝑠𝑠 < 𝑝𝑝𝑐𝑐; 𝑓𝑓(𝑝𝑝𝑑𝑑)is the maximum for region 𝑝𝑝𝑠𝑠𝑠𝑠 ≥ 𝑝𝑝𝑑𝑑. We 
assign 𝑠𝑠𝑠𝑠𝑠𝑠 according to the region of 𝑝𝑝𝑠𝑠𝑠𝑠 which produced the maximized 𝑓𝑓(𝑝𝑝𝑠𝑠𝑠𝑠). 
(5) If 𝑝𝑝𝑏𝑏 < ?̂?𝑝𝑠𝑠𝑠𝑠 < 𝑝𝑝𝑐𝑐, 𝑓𝑓(𝑝𝑝𝑎𝑎) is the maximum for restricted region 𝑝𝑝𝑠𝑠𝑠𝑠 ≤ 𝑝𝑝𝑎𝑎; 𝑓𝑓(𝑝𝑝𝑐𝑐) is the 
maximum for region 𝑝𝑝𝑏𝑏 < 𝑝𝑝𝑠𝑠𝑠𝑠 < 𝑝𝑝𝑐𝑐; 𝑓𝑓(?̂?𝑝𝑠𝑠𝑠𝑠) is the maximum for region 𝑝𝑝𝑠𝑠𝑠𝑠 ≥ 𝑝𝑝𝑑𝑑. We 
assign 𝑠𝑠𝑠𝑠𝑠𝑠 according to the region of 𝑝𝑝𝑠𝑠𝑠𝑠 which produced the maximized 𝑓𝑓(𝑝𝑝𝑠𝑠𝑠𝑠). 
2.2 EVALUATION CRITERIA 
In the simulation section, we will evaluate the accuracy, precision and bias of several 
methods by comparison. Accuracy and precision are compared between the Bayes’ method and 
the 1/3 rule; bias is compared among the Bayes’ method, the 1/3 rule, the observed methylation 
status, and the proportion of methylated reads from all observed reads without considering the 
single cell information as seen in bulk cell DNA methylation analysis. Accuracy is obtained from 
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the proportions of correct predictions for the three true methylation status groups, and for overall 
methylation levels of a region. Precision is calculated as the standard deviations of predicted 
methylation regions. To evaluate bias, we compute the average of differences between mean of 
predicted data and the real global methylation level for the region:𝜋𝜋𝑠𝑠(1/2)/2 + 𝜋𝜋𝑠𝑠(1). 
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3.0 SIMULATION 
3.1 SIMULATION SETTING 
We simulate the data for 𝐾𝐾 number of CpG sites using the following steps: 
1. Assign the overall methylation levels by selecting the proportions of unmethylated, 
50% methylated and methylated CpG sites as (𝜋𝜋𝑠𝑠
(0) , 𝜋𝜋𝑠𝑠(1/2)  and 𝜋𝜋𝑠𝑠(1) ). In this 
simulation study, we consider three scenarios: (1)  𝜋𝜋𝑠𝑠
(0) = 0.4, 𝜋𝜋𝑠𝑠(1/2)  = 0.1, and 𝜋𝜋𝑠𝑠(1) = 
0.5; (2)  𝜋𝜋𝑠𝑠
(0) = 0.3, 𝜋𝜋𝑠𝑠(1/2)  = 0.2, and (3)  𝜋𝜋𝑠𝑠(1) = 0.5; 𝜋𝜋𝑠𝑠(0) = 0.2, 𝜋𝜋𝑠𝑠(1/2)  = 0.1, and 𝜋𝜋𝑠𝑠(1) 
= 0.7.  Three scenarios are related to 55%, 60% and 75% overall methylation levels 
respectively. 
2. For each CpG site, we simulated total number of reads 𝑛𝑛 uniformly 2 to 31.  
3. Then randomly assign the methylation status for each CpG sites with proportion (𝜋𝜋𝑠𝑠
(0), 
𝜋𝜋𝑠𝑠
(1/2)  and 𝜋𝜋𝑠𝑠(1)).  For CpG sites,  assigned 𝑝𝑝𝑠𝑠𝑠𝑠 as the true proportion of methylated 
reads by considering the error rates: 𝑝𝑝𝑠𝑠𝑠𝑠~𝑈𝑈𝑛𝑛𝑖𝑖𝑓𝑓(0,𝑝𝑝𝑎𝑎) if 𝑠𝑠𝑠𝑠𝑠𝑠 = 0; 𝑝𝑝𝑠𝑠𝑠𝑠 ~𝑈𝑈𝑛𝑛𝑖𝑖𝑓𝑓(𝑝𝑝𝑏𝑏,𝑝𝑝𝑐𝑐) if 
𝑠𝑠𝑠𝑠𝑠𝑠 = 1/2; 𝑝𝑝𝑠𝑠𝑠𝑠~𝑈𝑈𝑛𝑛𝑖𝑖𝑓𝑓(𝑝𝑝𝑑𝑑, 1) if 𝑠𝑠𝑠𝑠𝑠𝑠 = 1.  
4. Since CG-contents may affect the overall reads, we simulated total number of reads 𝑛𝑛 
uniformly 2 to 41 if 𝑠𝑠𝑠𝑠𝑠𝑠 = 12 or 1, while sampled from 2 to 31 for CpG sites with 𝑠𝑠𝑠𝑠𝑠𝑠 =0. 
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5. Simulate the observed methylated reads 𝑦𝑦𝑠𝑠𝑠𝑠  at each CpG site from a binomial 
distribution, i.e. 𝑦𝑦𝑠𝑠𝑠𝑠|𝑝𝑝𝑠𝑠𝑠𝑠~𝐵𝐵𝑖𝑖𝑛𝑛(𝑛𝑛𝑠𝑠𝑠𝑠 ,𝑝𝑝𝑠𝑠𝑠𝑠). 
6. Apply the 1/3 rule on ?̂?𝑝𝑠𝑠𝑠𝑠 = 𝑦𝑦𝑠𝑠𝑠𝑠/𝑛𝑛𝑠𝑠𝑠𝑠, and obtain the hypothesized methylation level for 
later calculation. Similarly, our Bayes’ Rule method is applied on ?̂?𝑝𝑠𝑠𝑠𝑠  to get the 
hypothesized methylation statuses. 
7. Repeat the settings for 100 times and took the averaged results. 
  
3.2 SIMULATION RESULTS 
3.2.1  DNA METHYLATION DETECTION ACCURACY 
Table 1 shows the comparison between the Bayes’ method and the 1/3 rule about the 
accuracy of DNA methylation level prediction under sample size of 𝐾𝐾 = 100,000.  The 
comparison is conducted under 2 scenarios of the overall distribution methylation status on all 
CpG sites (𝜋𝜋𝑠𝑠
(0), 𝜋𝜋𝑠𝑠(1/2)  and 𝜋𝜋𝑠𝑠(1) ): Scenario I is 𝜋𝜋𝑠𝑠(0) = 0.4, 𝜋𝜋𝑠𝑠(1/2)  = 0.1, and 𝜋𝜋𝑠𝑠(1) = 0.5; Scenario 
II is 𝜋𝜋𝑠𝑠
(0) = 0.3, 𝜋𝜋𝑠𝑠(1/2)  = 0.2, and 𝜋𝜋𝑠𝑠(1) =0.5; Scenario III is 𝜋𝜋𝑠𝑠(0) = 0.2, 𝜋𝜋𝑠𝑠(1/2)  = 0.1, and 𝜋𝜋𝑠𝑠(1) =0.7.  
As we can see from Table 1, both methods capture correct methylation predictions well. 
Generally, Bayes’ method outperforms 1/3 rule in terms of higher correct proportions at the 
global level. Bayes’ method shows higher accuracy at underlying methylation levels of 0.5 and 1, 
whereas 1/3 rule performs better at 𝑠𝑠𝑠𝑠𝑠𝑠 = 0. 
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Table 1 Correct call proportions of the 2 methods with sample size 100,000 under 3 scenarios 
 Scenario I Scenario II Scenario III 
Bayes' method    
𝑠𝑠𝑠𝑠𝑠𝑠 = 0 0.993 0.986 0.989 
𝑠𝑠𝑠𝑠𝑠𝑠 = 0.5 0.741 0.809 0.748 
𝑠𝑠𝑠𝑠𝑠𝑠 = 1 0.997 0.995 0.998 
Global 0.970 0.955 0.971 
One-third rule    
𝑠𝑠𝑠𝑠𝑠𝑠 = 0 0.994 0.994 0.994 
𝑠𝑠𝑠𝑠𝑠𝑠 = 0.5 0.728 0.727 0.727 
𝑠𝑠𝑠𝑠𝑠𝑠 = 1 0.991 0.991 0.991 
Global 0.966 0.939 0.965 
3.2.2  DNA METHYLATION DETECTION PRECISION 
The standard errors of these 2 methods under different sample regions R and different 
scenarios are shown in Table 2. The 2 method show similar results with Bayes’ method acting 
slightly better under Scenario II and Scenario III. 
 
Table 2 Standard deviations of the 2 methods with different sample regions $ under 2 scenarios 
  R=50 R=100 R=200 
Scenario 
I 
Bayes' method 0.334 0.105 0.034 
One-third rule 0.334 0.105 0.034 
Scenario 
II 
Bayes' method 0.311 0.098 0.032 
One-third rule 0.316 0.100 0.032 
Scenario 
III 
Bayes' method 0.287 0.092 0.028 
One-third rule 0.289 0.093 0.029 
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3.2.3  DNA METHYLATION DETECTION BIAS 
The comparison of bias among all the 4 methods under different sample sizes K and 
scenarios is shown in Table 3. In Scenario I and Scenario II, the Bayes’ method outperformed 
others; Bayes’ method and 1/3 rule produced less bias than the other two methods. In Scenario 
III, the method of ∑𝒚𝒚𝒔𝒔𝒔𝒔 /∑𝒏𝒏𝒔𝒔𝒔𝒔 produced the smallest bias with the second smallest obtained 
from the Bayes’ method. It might be due to a high global methylation level in this scenario. 
 
Table 3 Biases produced by the 4 methods with different sample sizes K 
  K=100 K=1000 K=10,000 K=100,000 
  Scenario I   
Bayes' method -0.017 -0.016 -0.015 -0.016 
One-third rule -0.022 -0.022 -0.021 -0.022 
𝒑𝒑�𝒔𝒔𝒔𝒔 -0.023 -0.025 -0.023 -0.024 
∑𝒚𝒚𝒔𝒔𝒔𝒔 /∑𝒏𝒏𝒔𝒔𝒔𝒔  0.030 0.029 0.030 0.030 
Scenario I 
Bayes' method -0.008 -0.011 -0.010 -0.010 
One-third rule -0.019 -0.022 -0.021 -0.021 
𝒑𝒑�𝒔𝒔𝒔𝒔 -0.023 -0.026 -0.025 -0.025 
∑𝒚𝒚𝒔𝒔𝒔𝒔 /∑𝒏𝒏𝒔𝒔𝒔𝒔  0.023 0.022 0.023 0.022 
Scenario III 
Bayes' method -0.007 -0.009 -0.009 -0.009 
One-third rule -0.017 -0.019 -0.019 -0.019 
𝒑𝒑�𝒔𝒔𝒔𝒔 -0.038 -0.039 -0.039 -0.039 
∑𝒚𝒚𝒔𝒔𝒔𝒔 /∑𝒏𝒏𝒔𝒔𝒔𝒔  0.001 0.0001 0.001 0.001 
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3.3 CONCLUSTIONS OF SIMULATIONS 
From the simulation results from different situations, we can see that the biggest 
advantage of using the Bayes’ method is a more accurate methylation level prediction. Producing 
a less biased global mean is also a strength of this method compared to the one-third rule. Its 
benefit in the terms of precision is nuanced. Thus, overall, the Bayes’ method has a better 
performance than the one-third rule.  
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4.0 APPLICATION IN REAL DATA ANALYSIS 
4.1 DATA 
The data set is obtained from (Smallwood et al., 2014), which consists of 12 ovulated 
metaphase II oocytes (MII), 12 mouse embryonic stem cells (ESCs) cultured in two kinase 
inhibitors (2i), 20 ESCs cultured in serum conditions (Ser) and 7 negative control sc-BS-seq 
libraries. We selected the promoter regions among the dataset for analysis. Two kinase inhibitors 
have effect on reducing overall methylation levels.  
We plan to study the methylation differences between different types of cells. Figure 2 
shows an overall methylation level in promoter regions. The methylation levels from ESC Ser 
are higher compare to those from ESC 2i, showing the global hypomethylation for the cells in 
ESC 2i group (Figure 2 left panel). Another interesting finding is that methylation levels are very 
homogenous in MII group, which demonstrated that the methylation levels are changing 
heterogeneously with the development of cells. The control samples have very shallow 
sequencing depth compared to other groups with less than 1% of CpG sites covered.  
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Figure 2 Overall methylation levels and total number of CpG sites in promoter regions 
Methylation levels in ESC 2i samples are hypomethylated compared to those ESC Ser samples (left). The controls 
have very low coverage with less than 1% covered CpG sites (right). 
 
 
4.2 ERROR RATES ESTIMATION 
Ovulated metaphase II oocytes (MII) are haploid in which only one set of chomosome 
exists in these cells. Therefore, the methylation status for each of CpG sites can only be 0 or 
100%. To estimate the error rates of methylation status, we study this haploid samples. We 
collect CpG sites with 2, 3, … and so on number of reads. CpG sites with most reads covered is 
270.  For each group of CpG sites, the status should be either T (unmethylated) or C 
(methylated)  since all reads are from the same location.  We assume the small number of Ts or 
Cs are due to errors and sum them together, then calculate the proportion of error reads among 
the total reads collected. Figure 3 shows estimated error rates vesus number of CpG sites covered 
by sequencing reads. For cells MII 1 – 12 with shallow sequencing depth, the error rate is 
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increasing then decreasing over the number of reads covering the CpG sites. This is probably due 
to shallow sequencing depth, i.e., there are not enough CpG sites with large reads covered. 
However, when examing two cells with deeper sequencing depth, the error rates increase and 
then stay at around 10%, indicating the error rate is roughly at 10%. One panel (bottom left) is 
data for mixture of 120 bulk cells. Since methylation status in each cell is not homogeneous, it is 
expected to have larger estimated error rates because sequncing reads from different alleles may 
have different methylation status.   
 
Figure 3 Estimated error rates of methylation status among MII cells 
There are two cells (MII 2 and MII 5) with deeper sequencing depths. From these two deeper sequenced cells, we 
can roughly estimate that the error rate for methylation status call is about 10%. 
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4.3 APPLICATION IN DIFFERENTIALLY METHYLATION ANALYSIS 
We then applied our method as data preprocessing in a differentially methylation 
analysis. After calling methylation status with our Bayes’ method for CpG sites with multiple 
reads, we applied Beta-Binomial model in each promoter region to identify the differentially 
methylated ones. With clustering analysis, the differentially methylated promoter regions were 
clustered into groups of MII, ESC 2i and ESC Ser according to their similarity. Dendrogram was 
used to visualize the results (Figure 4). We can see that the cell types were segregated very well 
with only two from ESC Ser are misclassified as ESC 2i.   
 
 
Figure 4 A two way hierarchical cluster analysis of the relative methylation of promoter regions 
 
(Rows) measured on samples from 3 types of cells. Cell samples are identified on the top horizontal axis as red 
boxes (MII), green boxes (2i) and blue boxes (Ser). The methylation status of each region within each sample is 
presented in the image plot with values ranging from zero (red) to one (green; see color key). 
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5.0 DISCUSSION AND CONCLUSION 
In this thesis, we proposed a method based on Bayes rule to improve the accuracy on 
estimation of methylation status for single cell Bisulfite sequencing data. Simulation result 
shows that this method has better accuracy of methylation status calling when compared to one-
third rule. In terms of comparing the methylation level estimation for regions with different sizes 
(number of CpG sites), this proposed method has smaller bias and standard deviation compared 
to one-third rule method and the method to directly calculate from the observed methylation 
levels. The improvement in accuracy is the primary advantage of this method.  
In real data application, this method segregated cell types accurately as a preprocessing 
method in differential methylation analysis. In the future, this method can be applied into the 
imputation of unobserved methylation status. 
One limitation of our study is that the proposed method did not outperform other methods 
too much in reducing the bias obviously and improving efficiency. The benefit of accuracy in 
methylation status calling is consistent under various situations and discovering more other good 
features is in need for further study.  
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